Explore
Validate
Learn15963-1-AP
antibody from Proteintech Group
Targeting: PI3
cementoin, ELAFIN, ESI, SKALP, WAP3, WFDC14
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 15963-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- Elafin/Skalp antibody
- Antibody type
- Polyclonal
- Description
- Elafin/Skalp antibody (Cat. #15963-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IF, IHC,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Single-cell analysis identifies PI3+S100A7+keratinocytes in early cervical squamous cell carcinoma with HPV infection.
Elafin is related to immune infiltration and could predict the poor prognosis in ovarian cancer.
Spatiotemporal expression and regulation of peptidase inhibitor 3 and secretory leukocyte protease inhibitor at the maternal-fetal interface in pigs.
FAM3B Serves as a Biomarker for the Development and Malignancy of Oral Lichen Planus.
Development and external validation of a composite immune-clinical prognostic model associated with EGFR mutation in East-Asian patients with lung adenocarcinoma.
Fan P, Dong D, Feng Y, Zhu X, Wang R
Chinese medical journal 2025 Oct 20;138(20):2615-2630
Chinese medical journal 2025 Oct 20;138(20):2615-2630
Elafin is related to immune infiltration and could predict the poor prognosis in ovarian cancer.
Lu W, Xie B, Tan G, Dai W, Ren J, Pervaz S, Li K, Li F, Wang Y, Wang M
Frontiers in endocrinology 2023;14:1088944
Frontiers in endocrinology 2023;14:1088944
Spatiotemporal expression and regulation of peptidase inhibitor 3 and secretory leukocyte protease inhibitor at the maternal-fetal interface in pigs.
Lee S, Yoo I, Cheon Y, Ka H
Animal bioscience 2023 Jul;36(7):1034-1043
Animal bioscience 2023 Jul;36(7):1034-1043
FAM3B Serves as a Biomarker for the Development and Malignancy of Oral Lichen Planus.
Wang W, Wang M, Ahmed MMS, Zhao Y, Wu H, Musa M, Chen X
International journal of general medicine 2022;15:763-776
International journal of general medicine 2022;15:763-776
Development and external validation of a composite immune-clinical prognostic model associated with EGFR mutation in East-Asian patients with lung adenocarcinoma.
Liu C, Zheng S, Wang S, Wang X, Feng X, Sun N, He J
Therapeutic advances in medical oncology 2021;13:17588359211006949
Therapeutic advances in medical oncology 2021;13:17588359211006949
No comments: Submit comment
No validations: Submit validation data